Still Too Few Women in Stroke Treatment Clinical Trials

By Robert PreidtHealthDay Reporter TUESDAY, Oct. 19, 2021 (HealthDay News) — Men still outnumber women in stroke therapy clinical trials, which means women may end up receiving less effective treatment, researchers say. For the new study, investigators analyzed 281 stroke trials that included at least 100 patients each and were conducted between 1990 and 2020. … Read more

Latest Breast Cancer Clinical Trials: Who They’re For

webmd logo fb

Looking for clinical trials for breast cancer? Buckle up: There are more than 11,000 of them listed on to the official website, ClinicalTrials.gov. But you can winnow it down to the ones that fit you best. Here’s a look at what studies are happening  — and how to find one that you could join. Trends You Should … Read more

As Opioid Deaths Climb, Human Trials Begin for Vaccine

Sept. 15, 2021 — Opioid-related drug overdose deaths in the United States exploded to an estimated record high of 69,031 people in 2020, topping the 49,860 deaths logged in 2019, according to a new report from the CDC. Most of the deaths involved synthetic opioids such as fentanyl. President Joe Biden has pledged more … Read more

New Drug May Be Better Psoriasis Treatment

By Dennis Thompson HealthDay Reporter MONDAY, April 26, 2021 (HealthDay News) — A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a “night and day difference” in the results from bimekizumab compared against two established … Read more

Why Three Families Entered Kids in a COVID Vaccine Trial

Charles J. Gerardo, MD, professor and chief of emergency medicine, Duke University School of Medicine, Durham, NC. Jennifer L. Nayak, MD, chief of pediatric infectious diseases and associate professor of pediatrics and microbiology & immunology, University of Rochester Medical Center, Rochester, NY. Katherine Richards, senior research technician in immunology, University of Rochester Medical Center, Rochester, … Read more

Paving the Way for Diversity in Clinical Trials

Hala Borno, MD, assistant professor of medicine, Division of Oncology and Hematology, University of California, San Francisco Jamie Freedman, head of U.S. medical affairs, Genentech. Jennifer Jones-McMeans, PhD, director of global clinical affairs, Abbott Pharmaceuticals. Marya Shegog, PhD, health equity and diversity coordinator, Lazarex Cancer Foundation. Andrea Denicoff, registered nurse and nurse consultant, National Cancer … Read more

Nasal Spray Vaccine for COVID-19 in Early Trials

TUESDAY, Jan. 19, 2021 (HealthDay News) — A spritz instead of a shot to ward off COVID-19? Researchers report that a nasal spray vaccine against the new coronavirus shows promise in animal testing. Rodents that were given two doses of the vaccine had antibody and T-cell responses that were strong enough to suppress SARS-CoV-2, … Read more

Turkey approves China-based Sinovac vaccine’s emergency use

photo

ANKARA, TURKEY: Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotch Ltd. on Wednesday, paving the way for the rollout for Turkey’s vaccination program starting with health care workers and other high-risk groups. The country’s health minister and members of the country’s scientific advisory council received … Read more

WHO Says No to Remdesivir as COVID-19 Treatment

By Robert Preidt HealthDay Reporter FRIDAY, Nov. 20, 2020 (HealthDay News) — The antiviral drug remdesivir is not recommended for hospitalized COVID-19 patients because there’s no evidence that it reduces their need for ventilation or improves their chances of survival, a World Health Organization panel said Thursday. Remdesivir is regarded as a potential … Read more

Confidence Drops in Prescription-Strength Fish Oil

1800x1200 fish oil capsules

More than 13,000 patients, treated at centers around the world, were given either Epanova or a placebo pill containing corn oil. All patients had conditions putting them at at “high cardiovascular risk.” For example, they were being treated with cholesterol-lowering statins and had either blockages of the coronary arteries, or arteries in the brain or … Read more